CSIMarket



Sangui Biotech International Inc  (SGBI)
Other Ticker:  
 
 

SGBI's Net Cash Flow Growth by Quarter and Year

Sangui Biotech International Inc's Net Cash Flow results by quarter and year




SGBI Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter June - 0.02 - 0.01
III Quarter March 0.06 - - -0.02
II Quarter December -0.01 -0.01 -0.01 -0.01
I Quarter September -0.02 0.01 -0.01 0.03
FY   0.03 0.02 -0.02 0.01



SGBI Net Cash Flow third quarter 2022 Y/Y Growth Comment
Sangui Biotech International Inc in the third quarter 2022 achieved Net Cash Flow of $ 0.06 millions compare to net cash outflow recorded in same quarter a year ago.

Among companies who have reported third quarter 2022 results in the Biotechnology & Pharmaceuticals industry only one Company has achieved higher year on year Net Cash Flow results in the third quarter 2022. While Sangui Biotech International Inc' s Net Cash Flow no change of % ranks overall at the positon no. 46 in the third quarter 2022.




SGBI Net Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Sangui Biotech International Inc's third quarter 2022 Net Cash Flow $ 0.06 millions SGBI's Income Statement
Sangui Biotech International Inc's third quarter 2021 Net Cash Flow $ 0.00 millions Quarterly SGBI's Income Statement
New: More SGBI's historic Net Cash Flow Growth >>


SGBI Net Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




Net Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #2
Healthcare Sector #5
Overall #46

Net Cash Flow Y/Y Growth Statistics
High Average Low
2035.48 % 324.83 % -100 %
(Mar 31 2022)   (Dec 31 2016)
Net Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #2
Healthcare Sector #5
Overall #46
Net Cash Flow Y/Y Growth Statistics
High Average Low
2035.48 % 324.83 % -100 %
(Mar 31 2022)   (Dec 31 2016)

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Sangui Biotech International Inc's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
553.04 % 71.04 % -100 %
(Jun 30 2021)  


SGBI's III. Quarter Q/Q Net Cash Flow Comment
This turnaround III. Quarter 2022where Sangui Biotech International Inc published Net Cash Flow of $ 0.06 millions may be inception of better results.Sangui Biotech International Inc announced in the III. Quarter 2022 Net Cash Flow of $ 0.06 millions compare to net cash outflow recorded in previos quarter.

Within Biotechnology & Pharmaceuticals industry Sangui Biotech International Inc achieved highest sequential Net Cash Flow growth. While Sangui Biotech International Inc's Net Cash Flow growth quarter on quarter, overall rank is 0.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Statistics
High Average Low
553.04 % 71.04 % -100 %
(Jun 30 2021)  


SGBI's III. Quarter Q/Q Net Cash Flow Comment
This reversal of fortune III. Quarter 2022where Sangui Biotech International Inc delivered Net Cash Flow of $ 0.06 millions may be starting point of improved results.Sangui Biotech International Inc announced in the III. Quarter 2022 Net Cash Flow of $ 0.06 millions compare to net cash outflow recorded in previos quarter.

Within Biotechnology & Pharmaceuticals industry Sangui Biotech International Inc achieved highest sequential Net Cash Flow growth. While Sangui Biotech International Inc's Net Cash Flow growth quarter on quarter, overall rank is 0.


Sangui Biotech International Inc's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Net Cash Flow 12 Months Ending $ 0.06 $ -0.00 $ -0.01 $ 0.01 $ 0.00
Y / Y Net Cash Flow Growth (TTM) 107586.54 % - - - -
Year on Year Net Cash Flow Growth Overall Ranking # 8 # 0 # 0 # 0 # 8
Seqeuential Net Cash Flow Change (TTM) - - - 27757.69 % -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # 11 #




Cumulative Net Cash Flow growth Comment
With 107586.54% annual Net Cash Flow growth, Sangui Biotech International Inc would report a record annual Net Cash Flow surge if the fiscal year would end on Mar 31 2022.

Sangui Biotech International Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 8.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
27757.69 %
27757.69 %
27757.69 %
(Jun 30 2021)  

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector # 1
Overall # 8

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
107586.54 %
107586.54 %
107586.54 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0
Cumulative Net Cash Flow growth Comment
With 107586.54% annual Net Cash Flow growth, Sangui Biotech International Inc would report a record annual Net Cash Flow surge if the fiscal year would end on Mar 31 2022.

Sangui Biotech International Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 8.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
27757.69 %
27757.69 %
27757.69 %
(Jun 30 2021)  


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector # 1
Overall # 8

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
107586.54 %
107586.54 %
107586.54 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0




Other Net Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
SGBI's Net Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for SGBI's Competitors
Net Cash Flow Growth for Sangui Biotech International Inc's Suppliers
Net Cash Flow Growth for SGBI's Customers

You may also want to know
SGBI's Annual Growth Rates SGBI's Profitability Ratios SGBI's Asset Turnover Ratio SGBI's Dividend Growth
SGBI's Roe SGBI's Valuation Ratios SGBI's Financial Strength Ratios SGBI's Dividend Payout Ratio
SGBI's Roa SGBI's Inventory Turnover Ratio SGBI's Growth Rates SGBI's Dividend Comparisons



Companies with similar Net Cash Flow surge for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2022
Aikido Pharma Inc.-3.59%$ -3.589 millions
Quidelortho Corp-3.73%$ -3.732 millions
Brooklyn Immunotherapeutics Inc.-3.90%$ -3.901 millions
Lineage Cell Therapeutics Inc.-5.12%$ -5.116 millions
Cv Sciences Inc.-6.75%$ -6.748 millions
Tandem Diabetes Care Inc.-14.05%$ -14.050 millions
Eventbrite Inc.-14.36%$ -14.358 millions
Acer Therapeutics Inc.-20.21%$ -20.211 millions
Abcellera Biologics Inc.-23.09%$ -23.087 millions
China Health Industries Holdings Inc.-23.82%$ -23.817 millions
Cardiovascular Systems Inc.-29.81%$ -29.806 millions
Aclaris Therapeutics Inc.-31.89%$ -31.892 millions
Prophase Labs Inc.-33.82%$ -33.816 millions
Assertio Holdings inc.-38.93%$ -38.930 millions
Co diagnostics Inc.-40.49%$ -40.492 millions
International Stem Cell Corporation-46.96%$ -46.963 millions
Intra cellular Therapies Inc.-47.19%$ -47.193 millions
Phibro Animal Health Corporation-49.46%$ -49.461 millions
Landos Biopharma Inc -51.20%$ -51.202 millions
Plus Therapeutics Inc.-53.47%$ -53.467 millions
Clearside Biomedical Inc.-55.58%$ -55.576 millions
Geovax Labs Inc.-55.89%$ -55.891 millions
Diversified Healthcare Trust-55.98%$ -55.979 millions
Vaccinex Inc.-56.29%$ -56.292 millions
Ridgefield Acquisition Corp-56.53%$ -56.530 millions
Conmed Corporation-57.32%$ -57.325 millions
Celsion Corporation-57.39%$ -57.389 millions
Innoviva Inc.-58.03%$ -58.034 millions
Apollo Medical Holdings Inc.-59.31%$ -59.306 millions
Dariohealth Corp.-62.48%$ -62.484 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FOMC's Profile

Stock Price

FOMC's Financials

Business Description

Fundamentals

Charts & Quotes

FOMC's News

Suppliers

FOMC's Competitors

Customers & Markets

Economic Indicators

FOMC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071